RIMBP3

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RIMBP3 mutation is significantly associated with the immune_cell of many other genes, with 6 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RIMBP3-associated genes across cancer lineages are Erythrocytes, Mesangial cells, and mv Endothelial cells. Each is linked with RIMBP3 in more than 1 cancer types. Because this analysis shows association rather than direction, both RIMBP3-to-partner and partner-to-RIMBP3 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Erythrocytes grouped by RIMBP3-low versus RIMBP3-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RIMBP3→partner) and Y-score (partner→RIMBP3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECErythrocytes →+0.026+2.321.039.03631
UCECMesangial cells →-0.047-2.311.014.03631
UCECmv Endothelial cells →-0.031-2.311.008.03631
UCEClymphatic Endothelial cells →-0.028-3.405.017.00521
UCECMast cells →+0.021+3.502.008.00221
UCECEndothelial cells →-0.050-3.416.009.00511
Each partner links to its Q-omics profile. Showing the 6 strongest of 6 associations by consensus.

Erythrocytes by RIMBP3 expression — UCEC

Box plot of Erythrocytes in RIMBP3-low vs RIMBP3-high samples in UCEC.

Explore this box plot interactively →

Exploration